1. Home
  2. LEGN vs URBN Comparison

LEGN vs URBN Comparison

Compare LEGN & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • URBN
  • Stock Information
  • Founded
  • LEGN 2014
  • URBN 1970
  • Country
  • LEGN United States
  • URBN United States
  • Employees
  • LEGN N/A
  • URBN N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • URBN Clothing/Shoe/Accessory Stores
  • Sector
  • LEGN Health Care
  • URBN Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • URBN Nasdaq
  • Market Cap
  • LEGN 6.7B
  • URBN 6.8B
  • IPO Year
  • LEGN 2020
  • URBN 1993
  • Fundamental
  • Price
  • LEGN $34.47
  • URBN $70.09
  • Analyst Decision
  • LEGN Strong Buy
  • URBN Buy
  • Analyst Count
  • LEGN 12
  • URBN 11
  • Target Price
  • LEGN $73.36
  • URBN $81.91
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • URBN 2.3M
  • Earning Date
  • LEGN 11-11-2025
  • URBN 08-27-2025
  • Dividend Yield
  • LEGN N/A
  • URBN N/A
  • EPS Growth
  • LEGN N/A
  • URBN 55.85
  • EPS
  • LEGN N/A
  • URBN 5.10
  • Revenue
  • LEGN $796,838,000.00
  • URBN $5,832,231,000.00
  • Revenue This Year
  • LEGN $70.75
  • URBN $10.58
  • Revenue Next Year
  • LEGN $52.47
  • URBN $6.73
  • P/E Ratio
  • LEGN N/A
  • URBN $13.74
  • Revenue Growth
  • LEGN 74.75
  • URBN 9.63
  • 52 Week Low
  • LEGN $27.34
  • URBN $34.76
  • 52 Week High
  • LEGN $52.15
  • URBN $80.71
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 44.92
  • URBN 45.67
  • Support Level
  • LEGN $32.70
  • URBN $67.42
  • Resistance Level
  • LEGN $34.71
  • URBN $72.06
  • Average True Range (ATR)
  • LEGN 1.21
  • URBN 3.21
  • MACD
  • LEGN 0.07
  • URBN -0.06
  • Stochastic Oscillator
  • LEGN 46.90
  • URBN 34.00

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About URBN Urban Outfitters Inc.

Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.

Share on Social Networks: